Good Growth Opportunities in Global Cancer Biological Therapy Market FMI Releases New Report on the Cancer Biological T | Page 7

Report
Description
Report Description
estimated 16, 85,210 new cases will be diagnosed in 2016, in the US. Europe is the
second largest market .Asia pacific is expected to grow at a highest rate due to increasing
prevalence of cancer patient, better healthcare facilities and growing number of
insurance coverage. Japan contributes largest share in cancer treatment market in Asia
Pacific due to high prevalence of cancer in Japanese population.
Browse Full Report@
http://www.futuremarketinsights.com/reports/cancer-biological-therapy-market
Cancer Biological Therapy Market: Key Players
Some of the major players operating in the market for Cancer Biological Therapy
Market are F. Hoffmann-La Roche AG, Novartis International AG, Merck & Co., Inc.,
Amgen Inc., GlaxoSmithKline Plc, Bristol-Myers Squibb, Eli Lilly, Spectrum
Pharmaceuticals, Inc., Seattle Genetics, Inc., Celgene Corporation and others